TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Engages IBN for Corporate Communications Strategy
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), has engaged IBN to assist with its corporate communications strategy. Apimeds wholly owned subsidiary, MindWave Innovations, is developing institutional digital asset infrastructure connecting treasury, insurance, tokenized assets and blockchain ecosystems, with a platform combining insured custody, transparent reporting and technology-driven portfolio management to support risk-aware yield on Bitcoin reserves and institutional participation in the digital asset economy. IBN will leverage its investor-focused distribution network, including more than 5,000 syndication outlets, newsletters, social media channels, InvestorWire and other outreach tools, to generate greater awareness for Apimeds Pharmaceuticals US. To view the full press release,…